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ABSTRACT
Quorum-sensing (QS) peptides are biologically
attractive molecules, with a wide diversity of struc-
tures and prone to modifications altering or
presenting new functionalities. Therefore, the
Quorumpeps database (http://quorumpeps.ugent.
be) is developed to give a structured overview of
the QS oligopeptides, describing their microbial
origin (species), functionality (method, result and re-
ceptor), peptide links and chemical characteristics
(3D-structure-derived physicochemical properties).
The chemical diversity observed within this group
of QS signalling molecules can be used to develop
new synthetic bio-active compounds.
INTRODUCTION
Quorum sensing (QS) enables bacterial cells to establish
cell–cell communication and to regulate the expression
of speciﬁc genes in response to local changes in cell
density (1,2). The concept of intercellular communication
within bacterial populations originates from two inde-
pendent discoveries in the 1960s and 1970s. In 1965,
Tomasz (3) stated that a hormone-like extracellular
peptide was important for genetic competence in
Streptococcus pneumoniae. In 1970, Hastings and co-
workers reported that luminescence in the marine bacter-
ium Vibrio ﬁscheri was produced only at high cell density,
but not in dilute suspensions. They called the responsible
component ‘autoinducer’, which was later identiﬁed as
N-(3-oxohexanoyl)-homoserine lactone (4,5).
Several classes of microbially derived signalling
molecules have now been identiﬁed. In general, Gram-
negative QS bacteria use acylated homoserine lactones
(AHLs) as autoinducers, while Gram-positive bacteria
predominantly communicate with each other using oligo-
peptides that often contain chemical modiﬁcations (6).
In addition, a third family of compounds termed as
autoinducer-2, derived from the common precursor
4,5-dihydroxy-2,3-pentanedione, has been found to be
widespread in the bacterial world (7). Using these QS
signalling molecules, bacteria are able to regulate a
diverse array of physiological activities in a cell-
density-dependent manner. Processes controlled by QS
are usually those that are unproductive when undertaken
by an individual bacterium, but become effective when
undertaken by a group. Thus, QS allows bacteria to
behave like a multicellular organism. In addition to
genetic competence, bioluminescence, conjugation and
swarming motility, QS also controls virulence factor secre-
tion, bioﬁlm formation and sporulation (6,8–10).
In the past decade, a signiﬁcant increase in interest in
bacterial QS is noticed. The discovery of the QS-mediated
virulence factor expression in many clinically relevant
pathogens raised the idea of QS antagonist production.
Blocking QS is now recognized as a viable approach for
the development of novel antibiotics (11). Moreover, the
increased antimicrobial resistance, due to e.g. the forma-
tion of a bioﬁlm in which the micro-organisms are pro-
tected against antimicrobial chemotherapy and the
immune system of the host, has called the attention
to the QS system (12). Intriguingly, recent evidence indi-
cates chemical communication not only between bacteria
of different species but also between bacteria and host as
well. For example, AHLs have been found to be directly
recognized by eukaryotic cells and even to inﬂuence the
behaviour of eukaryotic organisms (immune suppression
and blood vessel relaxation) (2,13). These QS signalling
peptides may thus have diagnostic and therapeutic
properties in oncology and other pathologies as well (14).
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Peptides have recently attracted renewed attention for
their use in research, disease prevention, diagnosis and/or
therapy. These physiologically active molecules demon-
strate high afﬁnity, strong selectivity and low toxicity
and can be synthetically modiﬁed in order to optimize
their afﬁnity for a particular receptor and to display a
more speciﬁc biodistribution pattern (15,16). The main
drawback of the use of peptide-based compounds is
their low stability to peptidases and proteases found in
most tissues (16). However, metabolic stability can be
increased by substitution of unnatural amino acids or
D-isomers, amidation or acetylation of peptide termini,
cyclization and so on, hereby increasing the probability
of obtaining useful drugs, structurally related to the
parent lead peptides (17,18). Peptides can thus reverse
the increased attrition rate observed with small-molecule
drugs.
Seen the increased interest in bacterial QS signalling
molecules and the potential of peptides as new therapeutic
or diagnostic drugs, we present here a database of
(modiﬁed) QS peptides with the acronym ‘Quorumpeps’
(http://quorumpeps.ugent.be). This database encompasses
the structures and microbial origin as well as functionality
responses of the QS-derived signalling peptides, as
described in the literature.
ORGANIZATION OF THE DATABASE
Data model
In order to list all relevant data about the QS signalling
peptides, a relational database is constructed (19). The
usage of such a relational model facilitates the insertion
of new and/or additional data. Moreover, it avoids the
occurrence of duplicate data and data inconsistencies to
the largest extent possible. The schematic database model
is available through the Quorumpeps website
(Supplementary Figure S1). In this visual representation,
each block describes the structure of a table, with the table
name mentioned in the header of the block. In each block,
the names of the columns are listed. The column names
marked in bold font together determine the primary key of
the table. This means that the combination of values for
these columns is unique for each row in the table. For
clarity, the primary key columns are separated from the
other columns by means of a dotted line. Relationships
between tables are symbolized by an arrow.
The central table in the Quorumpeps database model is
‘Experiment’, representing the binding analysis of a
peptide (identiﬁed by MoleculeID) with a speciﬁc
receptor (identiﬁed by ReceptorName), using a given
method (identiﬁed by MethodName). The resulting
response (result type, measurement and unit) is also
given in this table. The table ‘Molecule’ summarizes the
chemical information about the peptides, including
the peptide name, the peptide chemical sequence, the
simpliﬁed molecular input line entry speciﬁcation
(SMILES) string and some physicochemical properties.
Moreover, also the optimized 3D-structure is given in
the database in .HIN format, acquired using
HyperChem 8.0 (Hypercube, Gainesville, FL, USA).
The bacterium that produces the signalling molecule is
given in the table ‘Origin’, while derived molecules are
connected to the molecules from which they are derived
through the table ‘Molecule_Modiﬁcation’. The receptors
are listed in the table ‘Receptor’. All methods used to
analyse the functionality of the peptides and the references
used are summarized in the tables ‘Method’ and
‘Publication’, respectively. The observed activity (e.g.
agonist or antagonist) of a peptide, bound to a speciﬁc
receptor, is stored in the additional table ‘Binding’.
The Quorumpeps database has been implemented on a
MySQL backend and is publicly available through the
website http://quorumpeps.ugent.be. The website is imple-
mented by using the content management system Drupal
and provides a simple, keyword-based search interface to
access the data available. Several search options are pre-
sented: peptide information (including sequence, trivial
name, SMILES or molecular formula), origin, functional-
ity method, receptor and literature information. Each per-
formed search results in an overview of peptides that
match the query. From this overview page, detailed infor-
mation about the selected peptides or related literature can
be obtained. User information can be found at the help
page of the Quorumpeps website.
Data collection
For loading information in the database, literature data
were gathered by using the search engines Web of
Knowledge, PubMed and Google, covering the period
1955–2012. The terms ‘QS’, ‘autoinducer’ and ‘phero-
mone’, each separately, as well as ‘peptide’, ‘agonist’ and
‘antagonist’, using the Boolean operation ‘AND’, were
used. The obtained literature was processed manually
and all relevant information was put in the database. In
order to expand the data available in the database, a data
submission page has been constructed on the website
allowing researchers to inform us of new information.
QUORUMPEPS IN DETAIL
Chemical information
The chemical information about the QS peptides includes
the IUPAC one-letter code amino acid sequence, with or
without any (post-translational) modiﬁcation, trivial
name, SMILES, molecular formula and physicochemical
properties (molecular weight, logP and isoelectric point
(pI)). The trivial name comprises every name that is
given to the speciﬁc peptide, thus allowing group names
(e.g. autoinducing peptide) as well as individual peptide
names (e.g. PhrA).
Before calculating the different physicochemical
properties, the geometrical structure of these QS
peptides was optimized using HyperChem 8.0. The
geometry optimization was obtained by the molecular
mechanics force ﬁeld method using the Polak–Ribie`re
conjugate gradient algorithm with a root mean square
gradient of 0.1 kcal/(A˚mol) as stop criterion.
Afterwards, these Cartesian coordinate matrices were
used to calculate the different descriptors, using
HyperChem 8.0 and Marvin Beans 5.3.3 (Chemaxon,
D656 Nucleic Acids Research, 2013, Vol. 41, Database issue
 at G
hent U
niversity on January 7, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Budapest, Hungary) software programs. This optimized
.HIN structure is available through the Quorumpeps
website, together with the 2D-SMILES notation. These
formats allow the user to perform any sort of analysis
on their various chemical properties, e.g. quantitative
structure-activity relationship (QSAR) or multivariate
data analysis (20). Diversity analysis using the diversity
index (described by the Tanimoto coefﬁcient) of the 231
QS peptides currently available in the Quorumpeps data-
base indicated that this dataset is extremely diverse
(DI=0.21) and thus suitable for QSAR or quantitative
structure–property relationship (QSPR) studies (21,22).
Species origin
In general, QS peptides are synthesized by Gram-positive
bacteria, e.g. Staphylococcus aureus and Bacillus subtilis.
As numerous different species are reported in the litera-
ture, an overview of all listed bacteria is available at the
Quorumpeps homepage, by using the information-icon:
using this scroll-list, rapid-directed searches can be per-
formed by the user of Quorumpeps.
Chemical modiﬁcations (e.g. amino acid substitution) of
an original QS peptide are visualized in the ‘Species origin’
section by referring to its original counterpart.
Functionality
The functional properties of the QS signalling peptides are
described in the Quorumpeps database. Moreover, an
overview of the receptors and methods can be found at
the homepage of Quorumpeps, using the information-icon
next to the appropriate characteristic.
The functionality of the signalling peptides is
characterized by the method used to study their QS
activity. The methods are using either the isolated
signalling peptides or the (genetically modiﬁed) bacteria
to investigate a biological activity. The target genes or
their products are then qualitatively or quantitatively
measured using antibacterial assays (23,24), biosensors
(25–31), bioﬁlm assays (32,33), analytical and immuno-
assays (34,35), DNA and RNA detection (36,37) or via-
bility measurements (34,38–41). Moreover, different QS
pathways are reported, which can be divided into mainly
cell membrane receptor-mediated activation and, to a
much lesser amount, cytoplasmic receptor activation
after cell penetration of the peptides. The majority of
QS peptides initiates a signalling pathway by activating
a membrane-integrated histidine kinase, after which the
cytoplasmic response regulator mediates the output
response. This cascade of reactions is species speciﬁc,
with homology seen between the different organisms.
Different pathways can be distinguished, which are given
in the Quorumpeps database: AgrC/AgrA and TRAP
virulence system (42–47), ComD/ComE competence
system (48), ComP/ComA and Rap competence or sporu-
lation system (49–52), FsrC/FsrA virulence system (53)
and NisK/NisR system or analogues (54,55).
Furthermore, also the quantitative binding results of the
QS peptides with a speciﬁc receptor are given in the
Quorumpeps database, in which agonistic or antagonistic
properties can be distinguished.
Links
This ‘Links’ section allows the user of Quorumpeps to link
the reported QS peptides through their binding properties
(i.e. receptor) or microbial origin. Peptides that bind with
the same receptor as the selected peptide are given in the
appropriate table, differentiating them based on their
agonist or antagonist activity. Moreover, peptides that
are synthesized by the same species are again listed in
this information section.
Literature
All information gathered to develop this Quorumpeps
database is summarized in the ‘Literature’ section,
described by a publication-ID; detailed information is
obtained after ID-selection: journal name, title, year and
author names in the same order as they appear on the
publication. Moreover, the possibility to download this
publication is also available, through their PubMed ID
number and related link.
CONCLUSION
This database (http://quorumpeps.ugent.be) gives an
overview of reported QS signalling peptides and their de-
rivatives, summarizing their chemical and functional
properties, together with species information. Therefore,
this database can function as a useful tool to justify
peptide choices for evaluating different responses or to
study QSPRs of these QS molecules. Quorumpeps will
quarterly be updated by the authors, ensuring up-to-date
information of this interesting and expanding ﬁeld for
other researchers.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figure 1.
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